Recruiting

Observational Study

Sponsor:

Baptist Health South Florida

Code:

NCT05756985

Conditions

Glioblastoma

Glioblastoma Multiforme

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Specimen Collection

Study Details

Brief summary:

To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA and also to compare the data obtained from this testing to imaging data found in the medical record. The goal of this study is to help us better understand what the glioblastoma tumor tissue looks like and how it functions. This understanding can lead to new therapies for the treatment of glioblastoma in the future.

Conditions

Glioblastoma

Glioblastoma Multiforme

Gliosarcoma

Study ID

NCT05756985

Start date

Dec 11, 2024

Status verified date

Jan, 2026

Completion date

Jan, 2029

Anticipated

Primary completion date

Jan, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Have the appearance of high-grade glioma on magnetic resonance (MR) imaging if allowed to consent and will undergo the procedure if the frozen is consistent with glioblastoma or gliosarcoma OR Patients with a history of histologically confirmed diagnosis of World Health Organization Grade glioblastoma or gliosarcoma that are undergoing repeat resection of a recurrent tumor as identified on preoperative MR imaging
2. Aged ≥ 18 years old
3. Contrast-enhancing tumor volume of at least 10 cc on the preoperative, volumetric MRI within 1 month prior to surgery
4. Provision of signed and dated informed consent form by participant or legally authorized representative (LAR), if applicable

Exclusion Criteria:

1\. Has a history or current evidence of any medical condition, therapy, or laboratory abnormality that might confound the results of the study or is not in the best interest of the participant, in the opinion of the treating investigator.

Study Design

Enrollment

120 participants

Anticipated

Interventions and Outcome Measures

Arms

Glioblastoma

Surgical tumor resection as standard of care and specimen collection

Interventions

Specimen Collection

Collect and preserve glioblastoma tissue for exploratory analyses to generate hypotheses for future studies.

Primary outcome measure

  • Number of glioblastoma (GBM) samples for analysis [ Time Frame: 2 years ]

Central Contacts and Locations

Central contacts

Locations

Miami Cancer Institute at Baptist Health, Inc.

Recruiting

Miami, Florida, United States, 33176

Contacts

More Information

Sponsor

Baptist Health South Florida

Last update posted

Feb 4, 2026

Last verified

Jan, 2026

Keywords

  • specimen banking

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Baptist Health South Florida on 2026-02-04.